CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 200 shares at $8.50 ($1,700)
- 4 Open-market buy Director bought 1,000 shares at $8.00 ($8,000)
- 4 Open-market buy Director bought 16 shares at $7.50 ($120)
- 4 Open-market buy Director bought 1,839 shares at $6.45 ($11,867)
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change · Other events
- 4 Option exercise 10% owner acquired 137,328 shares (option exercise)
- 4 Option exercise Director acquired 290,498 shares (option exercise)
- 4 Option exercise Director acquired 20,776 shares (option exercise)
- 4 Option exercise Director acquired 114,074 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 20,254 shares (option exercise)
- 4 Option exercise Director acquired 2,058 shares (option exercise)
- 4 Conversion 10% owner acquired 444,454 shares (conversion)
- SC 13D/A Stake Beneficial Ownership Report
Page 30 of 63 · 1,250 filings